Sterile 0.9% (w/v) Sodium Chloride
Sponsors
Glaxosmithkline Research & Development Limited
Conditions
Diabetic Peripheral Neuropathic PainKnee osteoarthritis pain
Phase 2
A multicentre randomized, double-blind, placebo-controlled, dose-finding, Phase 2 study (MARS-17) of GSK3858279 in adult participants with moderate to severe pain due to knee osteoarthritis.
CompletedCTIS2022-502799-22-00
Start: 2023-11-29End: 2024-08-05Target: 80Updated: 2024-06-26
A multicenter randomized, double-blind, placebo-controlled Phase 2 study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult participants with chronic Diabetic Peripheral Neuropathic Pain (DPNP) / NEPTUNE-17.
CompletedCTIS2022-502313-28-00
Start: 2023-12-14End: 2024-10-03Target: 80Updated: 2024-11-04